Clovis Oncology
CLVS
#10299
Rank
HK$91.56 M
Marketcap
HK$0.63
Share price
0.00%
Change (1 day)
-95.08%
Change (1 year)

Earnings for Clovis Oncology (CLVS)

Earnings in 2022 (TTM): -HK$1.71 Billion

According to Clovis Oncology's latest financial reports the company's current earnings are HK$0.13 Billion. In 2021 the company made an earning of -HK$1.82 Billion, an increase over its 2020 earnings that were of -HK$2.7 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clovis Oncology from 2010 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -HK$1.71 Billion-6.17%
2021 -HK$1.82 Billion-32.64%
2020 -HK$2.7 Billion-9.06%
2019 -HK$2.97 Billion7.49%
2018 -HK$2.76 Billion4.42%
2017 -HK$2.64 Billion-8.83%
2016 -HK$2.9 Billion-0.4%
2015 -HK$2.91 Billion140.82%
2014 -HK$1.21 Billion86.64%
2013 -HK$0.65 Billion19.53%
2012 -HK$0.55 Billion
2010 -HK$0.21 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$5.28 B-412.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$101.83 B-6,121.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$92.20 B-5,551.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.02 B-15,001.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$12.91 B-863.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.06 B-10,451.05%๐Ÿ‡บ๐Ÿ‡ธ USA